Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Novel combretastatin A-4 derivative containing aminophosphonates as dual inhibitors of tubulin and matrix metalloproteinases for lung cancer treatment
Xiaochao Huang, Yuanhang Chen, Wentian Zhong, et al.
European Journal of Medicinal Chemistry (2022) Vol. 244, pp. 114817-114817
Closed Access | Times Cited: 11

Showing 11 citing articles:

Recent Advances of Tubulin Inhibitors Targeting the Colchicine Binding Site for Cancer Therapy
Mohammed Hawash
Biomolecules (2022) Vol. 12, Iss. 12, pp. 1843-1843
Open Access | Times Cited: 66
Natural Products as Regulators against Matrix Metalloproteinases for the Treatment of Cancer
Md. Towhedul Islam, Nak Han Jang, Hyuck Jin Lee
Biomedicines (2024) Vol. 12, Iss. 4, pp. 794-794
Open Access | Times Cited: 10
Discovery of novel dual tubulin and MMPs inhibitors for the treatment of lung cancer and overcoming drug resistance
Guimei Li, Meng Wang, Li Luo, et al.
European Journal of Medicinal Chemistry (2025) Vol. 285, pp. 117249-117249
Closed Access
Novel tubulin polymerization inhibitors based on the hybridization of coumarin and indole ring: Design, synthesis and bioactivities evaluation
Wei Yang, Huining Peng, Min He, et al.
Journal of Molecular Structure (2024) Vol. 1305, pp. 137761-137761
Closed Access | Times Cited: 2
Hydrazylpyridine salicylaldehyde–copper(ii)–1,10-phenanthroline complexes as potential anticancer agents: synthesis, characterization and anticancer evaluation
Yating Chen, Zhilin Ke, Lingyu Yuan, et al.
Dalton Transactions (2023) Vol. 52, Iss. 35, pp. 12318-12331
Closed Access | Times Cited: 7
Hybridization of the Pharmacophoric Features of Discoipyrrole C and Combretastatin A‐4 toward New Anticancer Leads
Jais Kurian, Anvesh Ashtam, Akila Kesavan, et al.
ChemMedChem (2023) Vol. 18, Iss. 16
Closed Access | Times Cited: 2
Cytotoxic Activity of Distinct Families of Phosphonic Acid Derivatives – A Chemocentric Approach to Assess Their Molecular Action
György Dormán, Zsuzsanna Szalai, György Keglevich
ChemMedChem (2024) Vol. 19, Iss. 21
Open Access
Combretastatin A-4 based compounds as potential anticancer agents: A review
Moien A. Omar, Soha H. Emam, Demiana S. Mikhail, et al.
Bioorganic Chemistry (2024) Vol. 153, pp. 107930-107930
Closed Access
Matrix metalloproteases–targeting low-molecular-weight compounds
Cheorl‐Ho Kim
Elsevier eBooks (2024), pp. 501-516
Closed Access
Diastereoselective synthesis and biological evaluation of new fluorine-containing α-aminophosphonates as anticancer agents and scaffold to human urokinase plasminogen activator inhibitors
Karolina Ciesielska, Dariusz Wawrzyniak, Grzegorz Dutkiewicz, et al.
European Journal of Medicinal Chemistry (2024) Vol. 283, pp. 117116-117116
Closed Access
Design, Synthesis, Molecular Docking and Cytotoxicity of Stilbene-arylcinnamide Hybrids on A549 Lung Cancer Cells
Nurain Syazwani Mohd. Zaki, Nik Nur Syazni Nik Mohamad Kamal, Unang Supratman, et al.
Current Organic Chemistry (2023) Vol. 27, Iss. 16, pp. 1458-1470
Closed Access | Times Cited: 1
Page 1

Scroll to top